Chimeric antigen receptor T cells targeting CD312 as a therapy for acute myeloid leukemia

被引：0
|
作者：
Xie, Danni [1 ]
Wang, Bing [2 ]
Bai, Xue [2 ]
Jin, Xin [3 ]
Lu, Wenyi [2 ]
Zhang, Meng [1 ]
Zhang, Yi [1 ]
Cao, Xinping [1 ]
Zhao, Mingfeng [2 ]
机构：
[1] Tianjin Med Univ, Cent Clin Coll 1, Tianjin 300110, Peoples R China
[2] Tianjin First Cent Hosp, Dept Hematol, Tianjin 300192, Peoples R China
[3] Zhejiang Univ, Med Ctr, Liangzhu Lab, Hangzhou 310011, Zhejiang, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2025年 / 138卷 / 01期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1097/CM9.0000000000003362
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：114 / 116
页数：3
相关论文
共 50 条
  • [21] Chimeric Antigen Receptor T Cell Therapy in Acute Myeloid Leukemia: Trials and Tribulations
    Garg, Swati
    Ni, Wei
    Griffin, James D.
    Sattler, Martin
    HEMATOLOGY REPORTS, 2023, 15 (04) : 608 - 626
  • [22] Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia
    Schorr, Christopher
    Perna, Fabiana
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [23] Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
    Hofmann, Susanne
    Schubert, Maria-Luisa
    Wang, Lei
    He, Bailin
    Neuber, Brigitte
    Dreger, Peter
    Mueller-Tidow, Carsten
    Schmitt, Michael
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02)
  • [24] Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells
    Salman, Huda
    Pinz, Kevin G.
    Wada, Masayuki
    Shuai, Xiao
    Yan, Lulu E.
    Petrov, Jessica C.
    Ma, Yupo
    JOURNAL OF CANCER, 2019, 10 (18): : 4408 - 4419
  • [25] Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Acute Myeloid Leukemia
    Cartellieri, Marc
    Michalk, Irene
    von Bonin, Malte
    Krueger, Thomas
    Stamova, Slava
    Koristka, Stefanie
    Arndt, Claudia
    Feldmann, Anja
    Schmitz, Marc
    Wermke, Martin
    Lindemann, Dirk
    Bornhaeuser, Martin
    Ehninger, Gerhard
    Bachmann, Michael
    BLOOD, 2011, 118 (21) : 1124 - 1125
  • [26] EFFECTIVE TARGETING OF PRIMARY HUMAN ACUTE MYELOID LEUKEMIA USING ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR ENGINEERED T CELLS
    Gill, S.
    Tasian, S. K.
    Scholler, J.
    Porter, D. L.
    Carroll, M. P.
    Grupp, S. A.
    June, C.
    Kalos, M.
    CYTOTHERAPY, 2013, 15 (04) : S13 - S14
  • [27] Multi-Antigen Specific Chimeric Antigen Receptor T Cell Therapy for Acute Myeloid Leukemia
    Shrestha, Bishwas
    Vishwasrao, Paresh
    Li, Gongbo
    Boucher, Justin
    Kotani, Hiroshi
    Ghafoor, Tayyebb
    MOLECULAR THERAPY, 2019, 27 (04) : 269 - 269
  • [28] Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells
    Gill, Saar
    Tasian, Sarah K.
    Ruella, Marco
    Shestova, Olga
    Li, Yong
    Porter, David L.
    Carroll, Martin
    Danet-Desnoyers, Gwenn
    Scholler, John
    Grupp, Stephan A.
    June, Carl H.
    Kalos, Michael
    BLOOD, 2014, 123 (15) : 2343 - 2354
  • [29] Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia
    Yu, Wei
    Zhang, Hang
    Yuan, Yuncang
    Tang, Jie
    Chen, Xinchuan
    Liu, Ting
    Zhao, Xudong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [30] Chimeric antigen receptor T cell therapies for acute myeloid leukemia
    Bin Gu
    Jianhong Chu
    Depei Wu
    Frontiers of Medicine, 2020, 14 : 701 - 710
12345